PCA
BMRN icon

Private Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Private Capital Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,000
Closed -$811K – 97
2018
Q1 		$811K Buy
+10,000
New +$858K 0.27% 56
2017
Q1 		– Sell
-4,000
Closed -$331K – 119
2016
Q4 		$331K Buy
+4,000
New +$344K 0.11% 100
2015
Q3 		– Sell
-4,700
Closed -$643K – 114
2015
Q2 		$643K Buy
+4,700
New +$582K 0.21% 91
2013
Q4 		– Sell
-90,514
Closed -$6.53M – 107
2013
Q3 		$6.53M Sell
90,514
-30,836
-25% -$2.05M 2.37% 4
2013
Q2 		$6.76M Buy
+121,350
New +$7.56M 2.51% 3

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return